Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Diastolic Cardiomyopathy (Aim3)

NCT02058095 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Cardiomyopathy
Renal Impairment

Interventions

DRUG: Tadalafil
DRUG: Placebo

Sponsor

Mayo Clinic